California-based Solta Medical, a provider of solutions to the medical aesthetics market, is set to launch two new products the Clear + Brilliant laser and the Fraxel 1927 nm laser.

Solta plans to submit the CE-marked Clear + Brilliant for FDA 510K clearance this month.

Meanwhile, Fraxel 1927 nm laser which is authorized for sale in the US, Europe, and parts of Asia will be offered in a standalone package.

The company expects to begin shipping Clear+ Brilliant to customers in certain international markets in the second quarter of 2011 and Fraxel in March 2011 respectively.

Solta president and CEO Stephen Fanning said Clear+ Brilliant gives an effective and affordable solution for more youthful looking skin to a market segment that is not quite ready for more extensive procedures.

"We expect the introduction of these two new products to contribute to our growth in 2011 and beyond," Fanning said.